主辦 / 主持人
TUA泌腫委員會
積分
泌尿科(4點)、外科積分(申請中)
聯絡人
周小姐 wei791116@gmail.com
活動日期
2025-06-21 (六) 12:50 ~ 18:30
2025-06-22 (日) 09:00 ~ 11:30
地點
高雄漢來飯店
說明
ZOOM
會議號碼:853 3477 4783
會議連結
https://us06web.zoom.us/j/85334774783
2025-06-21 實體+【🎬線上】台灣泌尿科醫學會暨Uro-Oncology Post-ASCO/EAU Highlight
時間主題
12:50 ~ 13:00
opening
講者: 黃昭淵
13:00 ~ 13:15
Post-EAU 2025: Female Urology/ pediatric (On-line)
講者: 黃欣媚 座長: 林子平,
何承勳
13:15 ~ 13:30
Post-EAU 2025: BPH/ Andrology (On-line)
講者: 詹鎮豪 座長: 林子平,
何承勳
13:30 ~ 13:45
Post-EAU 2025: Urolithiasis/ transplantation
講者: 陳浩瑋 座長: 林子平,
何承勳
13:45 ~ 14:00
Break
講者: All
14:00 ~ 14:30
The Best of EAU25 in Urothelial Cancer (On-line)
講者: J.Boormans, Rotterdam (NL) 座長: 闕士傑,
廖俊厚
14:30 ~ 15:00
The Best of EAU25 in Functional Urology (On-line)
講者: Peyronnet, Rennes (FR) 座長: 闕士傑,
廖俊厚
15:00 ~ 15:30
The Best of EAU25 in Imaging (On-line)
講者: J.Walz, Marseille (FR) 座長: 闕士傑,
廖俊厚
15:30 ~ 15:50
Panel Discussion: Bridging European and Taiwanese Insights in Urology
講者: All
15:50 ~ 16:20
Re-thinking the First Step in mRCC: Bringing Evidence-Based Choices intoTaiwan’s NHI and Self-Pay Practice
講者: 蔡昇翰 座長: 林文榮
16:20 ~ 16:40
Navigating and Tailoring First-Line Therapy in metastatic/ advanced Renal Cell Carcinoma: Efficacy, and Side Effect Considerations
講者: 王紹全 座長: 許兆畬
16:40 ~ 17:00
Clinical outcomes ineligible patients for adjuvant therapy after nephrectomy based on the KEYNOTE-564 study criteria
講者: 郭威廷 座長: 虞凱傑
17:00 ~ 17:10
Break
講者: All
17:10 ~ 17:30
Beyond BRCA: examining the evidence for novel PARPi combinations in mCRPC
講者: 李香瑩 座長: 陳冠州
17:30 ~ 17:50
Breakthrough treatment for all comers: defeating prostate cancer together
講者: 廖丞晞 座長: 鍾旭東
17:50 ~ 18:10
New Horizons:Treatment Intensification in CSPC
講者: 陳毓騏 座長: 蔡育賢
18:10 ~ 18:20
Discussion
講者: All 座長: 陳冠州
18:20 ~ 18:30
Closing
講者: 查岱龍
2025-06-22 實體+【🎬線上】台灣泌尿科醫學會暨Uro-Oncology Post-ASCO/EAU Highlight 新增議程表 設定 報名管理
時間主題
09:00 ~ 09:10
opening
講者: 余家政
09:10 ~ 09:40
Transforming Perioperative Therapy : Challenges and Opportunities in Future MIBC Treatments
講者: 高建璋 座長: 闕士傑
09:40 ~ 10:10
The Role of IO Therapy in the Adjuvant Setting for Muscle-Invasive Bladder Cancer (MIBC)
講者: 陳鴻毅 座長: 李經家
10:10 ~ 10:40
LA/mUC Treatment Evolution: Insights from Congress and Real-World Application of ADC+IO
講者: 吳書丞 座長: 王賢祥
10:40 ~ 11:10
Advances and update of mUC upfront therapy in 2025
講者: 楊晨洸 座長: 張延驊
11:10 ~ 11:20
Discussion
講者: All 座長: 張延驊
11:20 ~ 11:30
Closing
講者: 李經家